Reduction in Baseline CD4 Count Testing Following Human Immunodeficiency Virus "Treat All" Adoption in Uganda.
Esther Nasuuna 
;
Mark W Tenforde;
Alex Muganzi;
Joseph N Jarvis ;
Yukari C Manabe;
Joanita Kigozi;
(2020)
Reduction in Baseline CD4 Count Testing Following Human Immunodeficiency Virus "Treat All" Adoption in Uganda.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71 (9).
pp. 2497-2499.
ISSN 1058-4838
DOI: 10.1093/cid/ciaa261
;
Mark W Tenforde;
Alex Muganzi;
Joseph N Jarvis ;
Yukari C Manabe;
Joanita Kigozi;
(2020)
Reduction in Baseline CD4 Count Testing Following Human Immunodeficiency Virus "Treat All" Adoption in Uganda.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71 (9).
pp. 2497-2499.
ISSN 1058-4838
DOI: 10.1093/cid/ciaa261
Baseline CD4 testing rates declined from 73% to 21% between 2013 and 2018 with adoption of "Treat All" in Uganda. Advanced human immunodeficiency virus (HIV) disease (CD4 count < 200 cells/µL) remained common (24% of those tested in 2018, 83% of whom had World Health Organization stage I/II disease). Despite frequent presentation with advanced HIV disease, CD4 testing has declined dramatically.
-
description - CID brief report 11 02 2020.docx
-
subject - Accepted Version
-
- Available under Creative Commons: NC-ND 3.0
Downloads